Skip to main content

Table 2 Amino acid substitutions in gyrA and parC and antimicrobial resistance profiles in 51 Salmonella isolates from poultry slaughterhouses by nalidixic acid resistance

From: Amino acid substitutions in gyrA and parC associated with quinolone resistance in nalidixic acid-resistant Salmonella isolates

Resistance pattern of nalidixic acid

Serovars (No. of isolates )

Amino acid substitution in*

MICs‡(mg/l)

Antimicrobial resistance profiles§

GyrA

ParC

Na

Cip

Resistant

Enteritis (18)

D87G

WT†

512

0.25

AmCSTe (1), AmS (2), STe (1)

512

0.5

AmCfS (2), AmS (2)

D87Y

WT

>512

0.5

- (8)

D87N

WT

>512

0.5

AmCfCzGmKCazCtxFepSTe (1), - (1)

Montevideo (5)

D87G

WT

>512

0.25

- (2)

512

0.25

- (3)

Senftenberg (2)

D87N

WT

512

0.5

- (1)

D87G

WT

512

0.25

- (1)

Newport (2)

D87Y

WT

512

0.5

- (1)

>512

0.5

- (1)

Susceptible

Typhimurium (8)

WT

WT

8

<0.0625

- (6)

8

0.25

- (1)

16

<0.0625

STe (1)

Montevideo (4)

WT

WT

4

<0.0625

GmK (2), - (2)

Hadar (5)

WT

WT

4

<0.0625

AmCfCzSTe (1)

8

<0.0625

AmCfCzKSTe (1), STe (2), KS (1)

Ohio (3)

WT

WT

4

<0.0625

STe (1), - (2)

London (3)

WT

WT

4

<0.0625

AmCfSTe (1)

8

<0.0625

- (2)

 

Hogton (1)

WT

WT

8

<0.0625

KSTe (1)

  1. *D, aspartic acid; G, glycine; N, asparagine; Y, tyrosine.
  2. †WT, wild type.
  3. ‡ Cip, ciprofloxacin; Na, nalidixic acid.
  4. §Am, ampicillin; C, chloramphenicol; Caz, ceftazidime; Cf, cephalothin; Cz, cefazolin; Ctx, cefotaxime; Fep, cefepime; Gm, gentamicin; K, kanamycin; S, streptomycin; Te, tetracycline.